Mark C. Gebhardt

Dr. Mark C. Gebhardt is an Orthopedic Surgeon and the Frederic W. and Jane M. Ilfeld Professor of Orthopedic Surgery at Harvard Medical School, affiliated with the Orthopedics and Sports Medicine Department at Boston Children's Hospital. His work spans clinical practice, research, and education.

Education:

• MD, University of Cincinnati College of Medicine (1975)
• Internship, University Health Center of Pittsburgh (1977)
• Residency, Harvard Combined Orthopedic Surgery Residency Program (1982)
• Fellowships in Orthopedic Surgery and Orthopedic Oncology at Boston Children's Hospital and Massachusetts General Hospital (1983)

Dr. Gebhardt's research focuses on bone tumors, chemotherapy efficacy, limb-sparing surgeries, and imaging techniques like CT/MRI for fracture prediction. He has contributed to understanding health disparities in orthopedic oncology and the use of AI in clinical research.

His recent publications emphasize pediatric bone sarcomas, multidisciplinary tumor conferences, and ethical considerations in race/ethnicity reporting. Trends include chemotherapy optimization, allograft complications, and functional outcomes.

Dr. Gebhardt has authored numerous articles in Clinical Orthopaedics and Related Research and other journals, with a focus on osteosarcoma, Ewing sarcoma, and soft tissue sarcomas. He has explored allograft reconstruction, radiation therapy, and molecular subtypes in tumors.

His career also involves clinical trials, including studies from the Children's Oncology Group and EURAMOS-1, addressing chemotherapy regimens and surgical outcomes. He has contributed to guidelines on tumor resection and reconstruction.